Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on impact of guideline changes on endocarditis prevention and an increase in oral streptococcal endocarditis among moderate-risk patients.
Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses insights from the PROGRESSA Study in a recently published original research paper on AI-enhanced prediction of aortic stenosis progression.
Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper about ongoing opioid treatment and symptoms of myocardial infarction in calls to the emergency medical services.
Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on impact of guideline-directed statin prescriptions on cardiovascular outcomes by race in a real-world primary prevention cohort.
Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances discusses a recently published original research paper about improving cardiovascular disease primary prevention treatment thresholds in a New England health care system.
Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on the association between periodontal disease and cardiovascular disease, including insights from imaging, observational, and genetic data.
Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on impact of the noninvasive diagnostic algorithm on clinical presentation and prognosis in cardiac amyloidosis.
Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on sex-related differences in left ventricular geometry patterns in patients with arterial hypertension.
Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published updated meta-analysis on impact of gender-affirming hormonal therapy on cardiovascular risk factors in transgender health.
Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on coronary artery calcium for risk stratification among persons with very high HDL cholesterol.
Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on left ventricular wall stress and incident heart failure in elderly community-dwelling individuals.
Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on AI-derived left ventricular mass from noncontrast cardiac CT including a correlation with contrast CT angiography and CMR.
Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on DPD quantification correlates with extracellular volume and disease severity in wild-type transthyretin cardiac amyloidosis.
Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on social vulnerability index and all-cause mortality after acute ischemic stroke for a Medicare Cohort from 2020-2023.
Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on cumulative radiation exposure and lifetime cancer risk in patients with Tetralogy of Fallot requiring early intervention.
Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper about high-performing Fontan patients in a Fontan outcome registry by cardiac magnetic resonance imaging study.
Sadeer Al-Kindi, MD, Sarju Ganatra, MD, and Sanjay Rajagopalan, MD, discuss the relationship between environmental pollutants and risk of cancer and cardiovascular disease. Moderated by Nicholas Wilcox, MD, MHS.
Sivatharshini Ramalingam, MD, Kazuhiro Sase, MD, PhD and Yugo Yamashita, MD, PhD, discuss evolving cardio-oncology in Japan, focusing on new guidelines, interdisciplinary care, and cancer-related cardiovascular risks.
Abdullah Al-Abcha, MD, social media editor of JACC: Cardiovascular Interventions, and Sung Gyun Ahn, MD, PhD, discuss a recently published original research paper reporting the outcomes of failed thrombus aspiration in patients with STEMI and large thrombus burden.
How does high physical activity level impact risk of incident carotid plaque components? Dr. Luosiyuan Zuo reported his research on how high physical activity level impacted the risk at ESC Congress 2024 and further discussed this topic based on the abstract for the ESC Congress 2024. Moderated by Dr. Zhangling Chen.
This issue features the first ever JACC: CardioOncology Expert Panel, providing consensus guidance and identifying the gaps in evidence in the cardiovascular care of our cancer patients. This is the first of a 3-part series focused on advancing evidence-based cardiovascular care prior to, during and after cancer therapy. Additionally, in this issue, we feature a number of high-impact state of the reviews, original research manuscripts and viewpoints.
In this episode of the JACC: CardioOncology Podcast, Antonio Cannata discusses the PROACT clinical trial, which investigated the effectiveness of enalapril in preventing cardiac damage in breast cancer and lymphoma patients undergoing anthracycline therapy. Despite neutral results, the conversation delves into the challenges of defining myocardial injury and emphasizes the need for improved risk stratification and innovative trial designs in future research.
In this episode, Brian Halliday discusses a Korean study examining the outcomes of patients with cancer therapeutics-related cardiac dysfunction after withdrawing cardioprotective therapy. He highlights that while patients with an ejection fraction between 45 and 55% fared similarly regardless of therapy continuation, those with an ejection fraction below 45% experienced worse outcomes when they withdrew treatment, underscoring the need for further randomized trials to refine therapeutic approaches.
In this episode, Dr. Sonia Shah explores a study from Australian researchers that evaluates the effectiveness of a polygenic risk score in predicting heart failure among cancer survivors. While the score enhanced prediction compared to age and sex alone, it did not significantly outperform existing modifiable risk factors, highlighting the need for more comprehensive models that account for unique risks faced by cancer patients.
In this episode, Brian Joyce discusses a groundbreaking study that examines the link between DNA methylation and the incidence of cardiovascular disease and cancer across three major cohorts. The research identifies shared epigenetic signatures associated with both diseases, highlighting the need for further investigation into their functional implications and potential clinical applications in diverse populations.